Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philip C. Robinson is active.

Publication


Featured researches published by Philip C. Robinson.


Nature Genetics | 2013

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

Adrian Cortes; Johanna Hadler; Jenny P. Pointon; Philip C. Robinson; Tugce Karaderi; Paul Leo; Katie Cremin; Karena Pryce; Jessica Harris; Seunghun Lee; Kyung Bin Joo; Seung Cheol Shim; Michael H. Weisman; Michael M. Ward; Xiaodong Zhou; Henri Jean Garchon; Gilles Chiocchia; Johannes Nossent; Benedicte A. Lie; Øystein Førre; Jaakko Tuomilehto; Kari Laiho; Lei Jiang; Yu Liu; Xin Wu; Linda A. Bradbury; Dirk Elewaut; Ruben Burgos-Vargas; Simon Stebbings; L. H. Appleton

Ankylosing spondylitis is a common, highly heritable inflammatory arthritis affecting primarily the spine and pelvis. In addition to HLA-B*27 alleles, 12 loci have previously been identified that are associated with ankylosing spondylitis in populations of European ancestry, and 2 associated loci have been identified in Asians. In this study, we used the Illumina Immunochip microarray to perform a case-control association study involving 10,619 individuals with ankylosing spondylitis (cases) and 15,145 controls. We identified 13 new risk loci and 12 additional ankylosing spondylitis–associated haplotypes at 11 loci. Two ankylosing spondylitis–associated regions have now been identified encoding four aminopeptidases that are involved in peptide processing before major histocompatibility complex (MHC) class I presentation. Protective variants at two of these loci are associated both with reduced aminopeptidase function and with MHC class I cell surface expression.


Arthritis & Rheumatism | 2014

Intestinal dysbiosis in ankylosing spondylitis.

Mary-Ellen Costello; Francesco Ciccia; Dana Willner; Nicole M. Warrington; Philip C. Robinson; Brooke Gardiner; Mhairi Marshall; Tony J. Kenna; Giovanni Triolo; Matthew A. Brown

Ankylosing spondylitis (AS) is a common, highly heritable immune‐mediated arthropathy that occurs in genetically susceptible individuals exposed to an unknown but likely ubiquitous environmental trigger. There is a close relationship between the gut and spondyloarthritis, as exemplified in patients with reactive arthritis, in whom a typically self‐limiting arthropathy follows either a gastrointestinal or urogenital infection. Microbial involvement in AS has been suggested; however, no definitive link has been established. The aim of this study was to determine whether the gut in patients with AS carries a distinct microbial signature compared with that in the gut of healthy control subjects.


Arthritis & Rheumatism | 2015

Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis

Mary-Ellen Costello; Francesco Ciccia; Dana Willner; Nicole M. Warrington; Philip C. Robinson; Brooke Gardiner; Mhairi Marshall; Tony J. Kenna; Giovanni Triolo; Matthew A. Brown

Ankylosing spondylitis (AS) is a common, highly heritable immune‐mediated arthropathy that occurs in genetically susceptible individuals exposed to an unknown but likely ubiquitous environmental trigger. There is a close relationship between the gut and spondyloarthritis, as exemplified in patients with reactive arthritis, in whom a typically self‐limiting arthropathy follows either a gastrointestinal or urogenital infection. Microbial involvement in AS has been suggested; however, no definitive link has been established. The aim of this study was to determine whether the gut in patients with AS carries a distinct microbial signature compared with that in the gut of healthy control subjects.


Molecular Immunology | 2014

Genetics of ankylosing spondylitis.

Philip C. Robinson; Matthew A. Brown

Ankylosing spondylitis (AS) is a chronic inflammatory arthritis that affects the spine and sacroiliac joints. It causes significant disability and is associated with a number of other features including peripheral arthritis, anterior uveitis, psoriasis and inflammatory bowel disease (IBD). Significant progress has been made in the genetics of AS have in the last five years, leading to new treatments in trial, and major leaps in understanding of the aetiopathogenesis of the disease.


Chemical Geology | 1986

Determination of rare-earth elements, yttrium and scandium in rocks by anion exchange—X-ray fluorescence technique

Philip C. Robinson; Neville C. Higgins; George A. Jenner

Abstract An ion exchange—X-ray fluorescence method for the determination of rare-earth elements (REE), Y and Sc in rocks and minerals is described. Samples are decomposed using a sodium peroxide sinter which dissolves even the most resistant minerals. A two-stage ion-exchange procedure, using hydrochloric and nitric acids, is used to separate other elements from the REE, Y and Sc which are adsorbed onto ion-exchange papers for XRF analysis. Data acquired on the international standard rocks using this technique compare favourably with the accepted values. These results, combined with precision checks on in-house standards, indicate that the precision and accuracy of this technique can be better than or equal to that of other well-established REE analytical techniques.


Nature Communications | 2015

Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.

Adrian Cortes; Sara L. Pulit; Paul Leo; J. J. Pointon; Philip C. Robinson; Michael H. Weisman; Michael M. Ward; Lianne S. Gensler; Xiaodong Zhou; Henri Jean Garchon; Gilles Chiocchia; Johannes Nossent; Benedicte A. Lie; Øystein Førre; Jaakko Tuomilehto; Kari Laiho; Linda A. Bradbury; Dirk Elewaut; Ruben Burgos-Vargas; Simon Stebbings; L. H. Appleton; Claire Farrah; Jonathan Lau; Nigil Haroon; J. Mulero; F.J. Blanco; Miguel A. González-Gay; Carlos López-Larrea; Paul Bowness; Karl Gaffney

Ankylosing spondylitis (AS) is a common, highly heritable, inflammatory arthritis for which HLA-B*27 is the major genetic risk factor, although its role in the aetiology of AS remains elusive. To better understand the genetic basis of the MHC susceptibility loci, we genotyped 7,264 MHC SNPs in 22,647 AS cases and controls of European descent. We impute SNPs, classical HLA alleles and amino-acid residues within HLA proteins, and tested these for association to AS status. Here we show that in addition to effects due to HLA-B*27 alleles, several other HLA-B alleles also affect susceptibility. After controlling for the associated haplotypes in HLA-B, we observe independent associations with variants in the HLA-A, HLA-DPB1 and HLA-DRB1 loci. We also demonstrate that the ERAP1 SNP rs30187 association is not restricted only to carriers of HLA-B*27 but also found in HLA-B*40:01 carriers independently of HLA-B*27 genotype.


Chemical Geology | 1980

Determination of calcium, magnesium, manganese, strontium, sodium and iron in the carbonate fraction of limestones and dolomites

Philip C. Robinson

A rapid atomic absorption spectrophotometric (AAS) method for the determination of Ca, Mg, Mn, Sr, Na and Fe in limestones and dolomites is described. After cold 1 M hydrochloric acid digestion, potassium chloride is added as a releasing agent and all elements are analysed on a single 100 × dilution. The AAS sensitivity for Ca and Mg is reduced by using the spectral overlap of Ge 422.66-nm and V 285.17-nm non-resonance lines with Ca 422.67-nm and Mg 285.21-nm resonance lines, respectively. Results are reported for four international standards. The extent of any trace element leaching from clay minerals by hydrochloric acid was determined by treating 21 Tasmanian limestones and dolomites with both weak 0.3 M acetic acid and the stronger 1 M hydrochloric acid. Analyses of Mn, Sr and Na show little difference between acids whereas Fe is dependent on acid strength.


Annals of the Rheumatic Diseases | 2013

Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis

Philip C. Robinson; B P Wordsworth; John D. Reveille; Matthew A. Brown

New classification criteria for axial spondyloarthritis have been developed with the goal of increasing sensitivity of criteria for early inflammatory spondyloarthritis. However these criteria substantially increase heterogeneity of the resulting disease group, reducing their value in both research and clinical settings. Further research to establish criteria based on better knowledge of the natural history of non-radiographic axial spondyloarthritis, its aetiopathogenesis and response to treatment is required. In the meantime the modified New York criteria for ankylosing spondylitis remain a very useful classification criteria set, defining a relatively homogenous group of cases for clinical use and research studies.


Internal Medicine Journal | 2012

Systematic review of the prevalence of gout and hyperuricaemia in Australia.

Philip C. Robinson; William J. Taylor; Tony R. Merriman

Aims:  Gout is a growing health problem worldwide especially in affluent countries, such as Australia. Gout and hyperuricaemia are associated with the metabolic syndrome, diabetes mellitus, obesity and hypertension. More importantly, Australia has a growing prevalence of these important health problems. The aim of this study was to systematically review published information regarding the prevalence of gout and hyperuricaemia in Australia.


Rheumatology | 2013

Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999–2009

Philip C. Robinson; Tony R. Merriman; Peter Herbison; John Highton

OBJECTIVES To describe the national demographics, comorbidities and mortality of admissions associated with gout in New Zealand (NZ) from 1999 to 2009 and compare this with English gout admission data from the same period. METHODS The characteristics of all admissions due to or complicated by gout in NZ from 1999 to 2009 were analysed. These findings were then compared with the wider NZ population and the English National Health Service (NHS) gout admission rates from 1999 to 2009. RESULTS There were 10 241 admissions due to gout (group A) and 34 318 admissions complicated by gout (group B) in NZ from 1999 to 2009. There were 32 741 admissions due to gout in England over the same period. Gout admissions rose at 5.5% per year in NZ and at 7.2% per year in England over the study period. NZ gout patients admitted to hospital were more likely to be Māori or a Pacific Islander and had 3-7 comorbidities. Multiple admissions were common with 1479 NZ gout patients admitted more than once. Comorbidities varied between the NZ groups A and B: hypertension (19-39%), renal disease (16-27%) and diabetes mellitus (20-27%) were common. Heart failure (27.6%) and cardiovascular disease (39.1%) were common in those who had gout complicating their hospital admission. This group also had poorer survival compared with those admitted primarily for gout. CONCLUSION This is the first study to describe the epidemiology of admissions associated with gout across an entire country. Admissions are rising in both countries studied and those admitted in NZ have a high rate of comorbidity and re-admission.

Collaboration


Dive into the Philip C. Robinson's collaboration.

Top Co-Authors

Avatar

Matthew A. Brown

Queensland University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Leo

Queensland University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tony J. Kenna

University of Queensland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael H. Weisman

Cedars-Sinai Medical Center

View shared research outputs
Top Co-Authors

Avatar

Jessica Harris

University of Queensland

View shared research outputs
Researchain Logo
Decentralizing Knowledge